Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 7Recruiting 4Terminated 3Active not recruiting 2Withdrawn 1Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 33Lung Neoplasms 18Breast Neoplasms 11Ovarian Neoplasms 10Uterine Cervical Neoplasms 6Carcinoma, Ovarian Epithelial 6Triple Negative Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Head and Neck Neoplasms 5Fallopian Tube Neoplasms 5Adenocarcinoma of Lung 5Neoplasms 4Neoplasm Metastasis 4Central Nervous System Neoplasms 4Esophageal Neoplasms 3Small Cell Lung Carcinoma 2Sarcoma 2Retinoblastoma 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Inflammatory Breast Neoplasms 2Gliosarcoma 2Glioblastoma 2Brain Neoplasms 2Adenocarcinoma, Bronchiolo-Alveolar 2Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thoracic Neoplasms 1Salivary Gland Neoplasms 1

Interventions

nirogacestat 1navoximod 1ixabepilone 1atezolizumab 1Topotecan 1Radiosurgery 1Pemetrexed 1Lapatinib 1Hydroxyurea 1Etoposide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Advanced Solid Tumors × Carboplatin × Clear all
NCT06719973 2025-06-17

Phase 1 Study of M9466 Combined With Carboplatin and Platinum-based Anticancer Therapy (DDRiver 521)

EMD Serono

Phase 1 Withdrawn
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡